Mind Medicine (MindMed) Inc
NASDAQ:MNMD

Watchlist Manager
Mind Medicine (MindMed) Inc Logo
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Watchlist
Price: 7.32 USD 3.39%
Market Cap: 536.8m USD
Have any thoughts about
Mind Medicine (MindMed) Inc?
Write Note

Mind Medicine (MindMed) Inc
Net Issuance of Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Mind Medicine (MindMed) Inc
Net Issuance of Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Issuance of Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
Net Issuance of Common Stock
$241.6m
CAGR 3-Years
13%
CAGR 5-Years
284%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Canopy Growth Corp
TSX:WEED
Net Issuance of Common Stock
CA$194.3m
CAGR 3-Years
8%
CAGR 5-Years
-48%
CAGR 10-Years
23%
Sundial Growers Inc
NASDAQ:SNDL
Net Issuance of Common Stock
-CA$1.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
Net Issuance of Common Stock
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
C
Curaleaf Holdings Inc
CNSX:CURA
Net Issuance of Common Stock
$63k
CAGR 3-Years
-87%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
No Stocks Found

Mind Medicine (MindMed) Inc
Glance View

Market Cap
536.8m USD
Industry
Pharmaceuticals

Mind Medicine (MindMed), Inc. operates as a neuro-pharmaceutical company that discovers, develops and deploys psychedelic medicines to improve health, promote wellness and alleviate suffering. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-05-04. The firm focuses on discovering, developing and deploying psychedelic-inspired medicines and therapies to address addiction and mental illness. The firm's commercial drug development programs includes lysergic acid diethylamide (LSD) experiential therapy, 18-methoxycoronaridine (18-MC) opioid withdrawal, LSD microdosing, methylenedioxymethamphetamine (MDMA), and dimethyltryptamine (DMT). The firm's subsidiaries include Mind Medicine, Inc., HealthMode, Inc., MindMed Pty Ltd. and MindMed GmbH.

MNMD Intrinsic Value
2.22 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Mind Medicine (MindMed) Inc's Net Issuance of Common Stock?
Net Issuance of Common Stock
241.6m USD

Based on the financial report for Sep 30, 2024, Mind Medicine (MindMed) Inc's Net Issuance of Common Stock amounts to 241.6m USD.

What is Mind Medicine (MindMed) Inc's Net Issuance of Common Stock growth rate?
Net Issuance of Common Stock CAGR 5Y
284%

Over the last year, the Net Issuance of Common Stock growth was 4 310%. The average annual Net Issuance of Common Stock growth rates for Mind Medicine (MindMed) Inc have been 13% over the past three years , 284% over the past five years .

Back to Top